+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

U.S. Contraceptive Market Size, Share & Trends Analysis Report by Product, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 80 Pages
  • March 2026
  • Region: United States
  • Grand View Research
  • ID: 4700900
The U.S. contraceptive market size was valued at USD 8.4 billion in 2025 and is expected to reach USD 12.4 billion by 2033, growing at a CAGR of 4.9% from 2026 to 2033. The increase in the use of modern contraceptives and the rise in awareness among adolescents and young people about sexual health and family planning are key factors driving the U.S. market growth.

Moreover, government programs have led to an increase in access to contraceptives that help prevent unwanted pregnancies in teenagers. The section below outlines key market factors such as research and development and trends shaping the women’s contraceptive health market. It highlights recent product launches, regulatory approvals, public health initiatives, and technological innovations that are expanding contraceptive choices, improving accessibility, and driving market growth in the U.S.

U.S. Contraceptive Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. contraceptive market report based on product and region.

Product Outlook (Revenue, USD Billion, 2021-2033)

  • Pills
  • Intrauterine Devices (IUD)
  • Hormonal IUD
  • Nonhormonal IUD
  • Condoms
  • Male Condoms
  • Female Condoms
  • Vaginal Ring
  • Subdermal Implants
  • Injectable
  • Others

Region Outlook (Revenue, USD Billion, 2021-2033)

  • West
  • Southeast
  • Southwest
  • Northeast
  • Midwest

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Contraceptive Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. U.S. Contraceptive Market: Product Movement Analysis
4.2. U.S. Contraceptive Market: Product Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2024 & 2033
4.4. U.S. Contraceptive Market Estimates & Forecast, by Product
4.5. Pills
4.5.1. Pills Market, 2021-2033 (USD Million)
4.6. Intrauterine Devices (IUD)
4.6.1. Intrauterine Devices (IUD) Market, 2021-2033 (USD Million)
4.6.2. Hormonal IUD
4.6.3. Nonhormonal IUD
4.7. Condoms
4.7.1. Condoms Market, 2021-2033 (USD Million)
4.7.2. Male Condoms
4.7.3. Female Condoms
4.8. Vaginal Ring
4.8.1. Vaginal Ring Market, 2021-2033 (USD Million)
4.9. Subdermal Implants
4.9.1. Subdermal Implants Market, 2021-2033 (USD Million)
4.10. Injectable
4.10.1. Injectable Market, 2021-2033 (USD Million)
4.11. Others
4.11.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Region Business Analysis
5.1. U.S. Contraceptive Market: Region Movement Analysis
5.2. U.S. Contraceptive Market: Region Segment Dashboard
5.3. Region Movement & Market Share Analysis, 2025 & 2033
5.4. U.S. Contraceptive Market Estimates & Forecast, by Region
5.5. West
5.5.1. West Market, 2021-2033 (USD Million)
5.6. Southeast
5.6.1. Southeast Market, 2021-2033 (USD Million)
5.7. Southwest
5.7.1. Southwest Market, 2021-2033 (USD Million)
5.8. Northeast
5.8.1. Northeast Market, 2021-2033 (USD Million)
5.9. Midwest
5.9.1. Midwest Market, 2021-2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Position Analysis, 2025
6.3. Strategy Mapping
6.3.1. Mergers & Acquisitions
6.3.2. Partnership and Collaborations
6.3.3. New Product Launch
6.3.4. Others
6.4. Company Profiles/Listing
6.4.1. Church & Dwight Co., Inc.
6.4.2. Reckitt Benckiser Group Plc
6.4.3. Organon Group of Companies
6.4.4. Pfizer, Inc.
6.4.5. Teva Pharmaceutical Industries Ltd.
6.4.6. The Cooper Companies, Inc.
6.4.7. Mayer Laboratories Inc
6.4.8. Agile Therapeutics
6.4.9. Mayne Pharma Group Limited.
6.4.10. Bayer AG
6.4.11. Afaxys, Inc.
6.4.12. AbbVie
6.4.13. Gedeon Richter
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Contraceptive methods and associated side effects
Table 4 Classification of contraceptives by the U.S. FDA
Table 5 States that have expanded contraceptive coverage guarantee in the Affordable Care Act
Table 6 Types of oral contraceptives, composition, and regimen
Table 7 List of intrauterine devices currently available in the U.S.
Table 8 Types of male condom variants
Table 9 US contraceptive market revenue estimates and forecast, by product, 2021-2033 (USD Million)
Table 10 US contraceptive market revenue estimates and forecast, by region, 2021-2033 (USD Million)
List of Figures
Figure 1 U.S. contraceptive market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape
Figure 12 U.S. contraceptive market: Parent market outlook
Figure 13 U.S. contraceptive market dynamics
Figure 14 Market driver relevance analysis (Current & future impact)
Figure 15 Market restraint relevance analysis (Current & future impact)
Figure 16 U.S. contraceptive market: Porter’s five forces analysis
Figure 17 U.S. contraceptive market: PESTLE analysis
Figure 18 U.S. contraceptive market: product segment dashboard
Figure 19 U.S. contraceptive market: product market share analysis, 2024 & 2033
Figure 20 Pills market, 2021-2033 (USD Million)
Figure 21 Intrauterine Devices (IUD) market, 2021-2033 (USD Million)
Figure 22 Hormonal IUD market, 2021-2033 (USD Million)
Figure 23 Nonhormonal IUD market, 2021-2033 (USD Million)
Figure 24 Condoms market, 2021-2033 (USD Million)
Figure 25 Male condoms market, 2021-2033 (USD Million)
Figure 26 Female condoms market, 2021-2033 (USD Million)
Figure 27 Vaginal ring market, 2021-2033 (USD Million)
Figure 28 Subdermal implants market, 2021-2033 (USD Million)
Figure 29 Injectable market, 2021-2033 (USD Million)
Figure 30 Others market, 2021-2033 (USD Million)
Figure 31 U.S. contraceptive market: Region segment dashboard
Figure 32 U.S. contraceptive market: Region market share analysis, 2025 & 2033
Figure 33 Southeast market, 2021-2033 (USD Billion)
Figure 34 West market, 2021-2033 (USD Billion)
Figure 35 Midwest market, 2021-2033 (USD Billion)
Figure 36 Northeast market, 2021-2033 (USD Billion)
Figure 37 Southwest market, 2021-2033 (USD Billion)
Figure 38 Company/competition categorization
Figure 39 Company market position analysis, 2025
Figure 40 U.S. contraceptive market: Strategy mapping

Companies Mentioned

  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group Plc
  • Organon Group of Companies
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • The Cooper Companies, Inc.
  • Mayer Laboratories Inc
  • Agile Therapeutics
  • Mayne Pharma Group Limited.
  • Bayer AG
  • Afaxys, Inc.
  • AbbVie
  • Gedeon Richter

Table Information